CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
fluticasone nasal spray +2 moredrug
Likely dose
fluticasone nasal spray 50 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02194062
NCT02194062N/ACompleted

A Comparison of Budesonide Nasal Irrigation in Different Head Positions and Fluticasone Nasal Spray in Post-operative Functional Endoscopic Sinus Surgery Patients With Chronic Rhinosinusitis With Nasal Polyposis

Yale University·interventional·Posted Jul 18, 2014·Updated Feb 8, 2018

In Brief

A clinical study evaluating fluticasone nasal spray, Budesonide head upright, and 1 other intervention for Sinusitis and Nasal Polyps. Completed, enrolled 32 participants across 2 sites.

Detailed Summary

The purpose of this study is to compare intranasal fluticasone spray with budesonide nasal saline rinses in both the upright and head forward positions in patients who have had functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis with nasal polyposis (CRSwNP) and measure differences in Sinonasal Outcome Test-22 (SNOT-22) scores and Lund- Kennedy scores on rigid nasal endoscopy at time points 1 week, 3 weeks, 6 weeks, 2 months, 4 months, and 6 months post-op.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 18, 2014
Enrollment StartJan 1, 2015
Primary CompletionJul 1, 2015
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 12.0 years ago

Interventions

fluticasone nasal spraydrug

use 2-50 mcg sprays to each nostril two times per day

Budesonide head uprightdrug

(0.5 mg/2mL) to instill into each nostril in the upright position two times per day

Budesonide head forwarddrug

(0.5 mg/2mL) to instill into each nostril in the head forward position two times per day